Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer

The Breast 2026 Open access

Read full text
Authors: Carmine Valenza, Ann H. Partridge, Meredith M. Regan
DOI: 10.1016/j.breast.2026.104696
Cited by: 2
References: 15

Abstract

This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.

Fields of Study & Subjects

Breast Cancer Treatment Studies Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research

Publication details

Journal / source
The Breast
Publisher
Elsevier BV
Volume
85
Pages
104696–104696
Publication date
12 January 2026
Language
EN